How have ABCZF shares performed in 2024?

Abcam's stock was trading at C$22.25 at the start of the year. Since then, ABCZF shares have increased by 0.0% and is now trading at C$22.25. View the best growth stocks for 2024 here .

Is Abcam a good dividend stock?

Abcam (OTCMKTS:ABCZF) pays an annual dividend of C$0.07 per share and currently has a dividend yield of 1.93%. The dividend payout ratio is 42.48%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Abcam?

Shares of ABCZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ABCZF

Abcam (ABCZF) Stock Price, News & Analysis

→ Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad)

Free ABCZF Stock Alerts

C$22.25

0.00 (0.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: C$22.25
▼
C$22.25
50-Day Range: C$22.25
▼
C$22.25
52-Week Range: C$5.00
▼
C$23.80

Volume: N/A
Average Volume: 2,659 shs
Market Capitalization: N/A

P/E Ratio: 130.73
Dividend Yield: 0.32%
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Short Interest

Get Abcam alerts:

Ad Colonial Metals

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

About Abcam Stock (OTCMKTS:ABCZF)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation.

ABCZF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ABCZF Stock News Headlines

July 13, 2022 | benzinga.com

Abcam (OTC:ABCZF), Short Interest Report

July 12, 2022 | benzinga.com

Abcam (OTC:ABCZF), Earnings Estimates, EPS, and Revenue

April 26, 2024 | Prosper Trading Academy (Ad)

These AI trades triggered this morning (545% return)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

May 20, 2022 | uk.finance.yahoo.com

Which way now for the Abcam share price?

See More Headlines

Receive ABCZF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:ABCZF
CUSIP: N/A
CIK: 1492074
Web: abcam.com
Phone: 441223696000
Fax: N/A
Employees: 1,760
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 130.73
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Alan Thomas Hirzel BS (Age 56)
M.B.A., M.S., CEO & Executive Director
Comp: $1.21M
Mr. Michael Shaun Baldock B.A. (Age 60)
CFO & Director
Comp: $894.85k
Marc Leigh Russell Perkins
General Counsel & Company Secretary
Emma Sceats
Senior Vice President of Sales & Marketing
Mr. Nick Skinner
Senior Vice President of Human Resources
Ms. Alejandra Solache Ph.D.
Senior Vice President of Research & Development
Mr. John Baker
Senior Vice President of Supply Chain & Manufacturing
Juan Carlos Sacristan
Senior Vice President of Data & Digital

Key Competitors

View All Competitors

ABCZF Stock Analysis - Frequently Asked Questions

How have ABCZF shares performed in 2024?: Abcam's stock was trading at C$22.25 at the start of the year. Since then, ABCZF shares have increased by 0.0% and is now trading at C$22.25.
View the best growth stocks for 2024 here.
Is Abcam a good dividend stock?: Abcam (OTCMKTS:ABCZF) pays an annual dividend of C$0.07 per share and currently has a dividend yield of 1.93%. The dividend payout ratio is 42.48%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Abcam?: Shares of ABCZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ABCZF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial